Co-Diagnostics, Inc.
CODX
$0.34
-$0.01-2.01%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 39.29% | -1.72% | 19.10% | 24.84% | -62.09% |
| Total Depreciation and Amortization | -23.86% | -13.86% | -15.18% | 14.13% | 18.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -43.42% | -82.33% | -117.35% | -91.52% | 266.23% |
| Change in Net Operating Assets | -163.31% | -480.43% | -155.73% | 48.48% | 174.89% |
| Cash from Operations | 18.33% | -59.25% | -3.00% | -72.25% | -25.40% |
| Capital Expenditure | 56.94% | -306.80% | 77.16% | 84.29% | 26.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -48.19% | 543.72% | -56.38% | -96.64% | 68.51% |
| Cash from Investing | -47.82% | 522.95% | -55.87% | -97.23% | 78.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 165.06% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.74% | 199.69% | -112.63% | -268.08% | 14.75% |